Literature DB >> 8876020

Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory.

J Shepherd1, D J Bill, C T Dourish, S S Grewal, A McLenachan, K J Stanhope.   

Abstract

There is increasing interest in the potential functional role of the octapeptide angiotensin II (AII) in psychiatric and cognitive disorders. The novel angiotensin II (AII) receptor antagonists, losartan and PD123177, selective for the AT1 and AT2 receptor subtypes respectively, constitute important pharmacological tools for the assessment of the behavioural consequences of modulation of AII function. The present series of studies investigated the effects of each compound in two animal models of anxiety, the rat elevated zero-maze and mouse light/dark box, and two models of working memory in the rat, the operant delayed matching to position (DMTP) task and the spatial reinforced alternation test in the T-maze. Our data indicate that both compounds (0.01-10 mg/kg s.c.) were without significant effect in any of the behavioural assays. Using the present methods and strains of laboratory rodents, these findings provide no support for the involvement of AII receptor function in the mediation of anxiety of working memory.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876020     DOI: 10.1007/bf02246450

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Non-peptide angiotensin II receptor antagonists discriminate subtypes of 125I-angiotensin II binding sites in the rat brain.

Authors:  D R Gehlert; S L Gackenheimer; J K Reel; H S Lin; M I Steinberg
Journal:  Eur J Pharmacol       Date:  1990-10-02       Impact factor: 4.432

2.  Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.

Authors:  B Costall; A M Domeney; P A Gerrard; Z P Horovitz; M E Kelly; R J Naylor; D M Tomkins
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

3.  Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats.

Authors:  S B Dunnett
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Alzheimer's dementia produces a loss of discrimination but no increase in rate of memory decay in delayed matching to sample.

Authors:  E A Money; R C Kirk; N McNaughton
Journal:  Neuropsychologia       Date:  1992-02       Impact factor: 3.139

5.  Drinking induced by subcutaneous injection of angiotensin II in the rat is blocked by the selective AT1 receptor antagonist DuP 753 but not by the selective AT2 receptor antagonist WL 19.

Authors:  C T Dourish; J A Duggan; R J Banks
Journal:  Eur J Pharmacol       Date:  1992-01-28       Impact factor: 4.432

6.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

7.  Binding of angiotensin antagonists to rat liver and brain membranes measured ex vivo.

Authors:  F H Marshall; S A Clark; A D Michel; J C Barnes
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Exploration of mice in a black and white test box: validation as a model of anxiety.

Authors:  B Costall; B J Jones; M E Kelly; R J Naylor; D M Tomkins
Journal:  Pharmacol Biochem Behav       Date:  1989-03       Impact factor: 3.533

9.  The effects of ACE inhibitors captopril and SQ29,852 in rodent tests of cognition.

Authors:  B Costall; J Coughlan; Z P Horovitz; M E Kelly; R J Naylor; D M Tomkins
Journal:  Pharmacol Biochem Behav       Date:  1989-07       Impact factor: 3.533

10.  A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson's disease.

Authors:  B J Sahakian; R G Morris; J L Evenden; A Heald; R Levy; M Philpot; T W Robbins
Journal:  Brain       Date:  1988-06       Impact factor: 13.501

View more
  2 in total

1.  Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.

Authors:  Santoshkumar Tota; Kashif Hanif; Pradeep Kumar Kamat; Abul Kalam Najmi; Chandishwar Nath
Journal:  Psychopharmacology (Berl)       Date:  2012-02-24       Impact factor: 4.530

2.  Cognitive enhancement following acute losartan in normotensive young adults.

Authors:  Rasha Mechaeil; Paul Gard; Anne Jackson; Jennifer Rusted
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.